US Patent No. 9,296,823

Diagnosis and treatment of cancer using anti-GPR49 antibody
Apr 08, 2016

Chugai Seiyaku Kabushiki Kaisha has been awarded US Patent No. 9,296,823, "Diagnosis and treatment of cancer using anti-GPR49 antibody."

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.

Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.